Case Study Interpreting, Processing, and Preparing to Compound an IV Admixture Order Mr. Smith, who is a patient on the surgical unit, is suffering from a bacterial wound infection. He has been prescribed sodium chloride 0.9% continuous IV and 2 g of cloxacillin IV in a 50-mL MiniBag of D5W to be administered every 8 hours. The cloxacillin IV is to be infused over 30 minutes. Your pharmacy caries 2-g vials of cloxacillin powder requiring the addition of 6.5 mL of sterile water for injection for reconstitution, yielding a final volume of 8 mL stock solution. What is the first thing you would do after receiving this order? (Napra 3.1) What would be the concentration of cloxacillin per millilitre of stock solution? (Napra 3.1) What is the volume of the cloxacillin powder? (Napra 3.1) What would be the concentration of cloxacillin per millilitre in the MiniBag of D5W? (Napra 3.1) How many MiniBags would you send to the surgical unit to cover 24 hours of treatment? (Napra 3.1)

Case Study Interpreting, Processing, and Preparing to Compound an IV Admixture Order Mr. Smith, who is a patient on the surgical unit, is suffering from a bacterial wound infection. He has been prescribed sodium chloride 0.9% continuous IV and 2 g of cloxacillin IV in a 50-mL MiniBag of D5W to be administered every 8 hours. The cloxacillin IV is to be infused over 30 minutes. Your pharmacy caries 2-g vials of cloxacillin powder requiring the addition of 6.5 mL of sterile water for injection for reconstitution, yielding a final volume of 8 mL stock solution. What is the first thing you would do after receiving this order? (Napra 3.1) What would be the concentration of cloxacillin per millilitre of stock solution? (Napra 3.1) What is the volume of the cloxacillin powder? (Napra 3.1) What would be the concentration of cloxacillin per millilitre in the MiniBag of D5W? (Napra 3.1) How many MiniBags would you send to the surgical unit to cover 24 hours of treatment? (Napra 3.1)

Surgical Tech For Surgical Tech Pos Care

5th Edition

ISBN:9781337648868

Author:Association

Publisher:Association

Chapter7: Preventing Perioperative Disease Transmission

Section: Chapter Questions

Problem 7.2.2CS

See similar textbooks

Similar questions

Topic: IV Solution 1. What are the required sources for you to confirm the patient's identity before administering medication of IV solution? 2. What information about the drug should you determine prior to administration of IV Solution? 3. What are the contents of an IV additive label? 4. What are the nursing considerations to prevent medication errors?
Topic: Pharmacology Critically read the provided article, Venous Thromboembolism Prophylaxis: Therole of the nurse in changing practice and saving lives. Use the informationprovided by the article and lecture notes to answer the following questions. i) What are factors that put Medical Patients at high risk for venousthromboembolism? ii) What are factors that put Surgical Patients at high risk for venousthromboembolism (VTE)?
Case Study Four Case Study Assessing Dose Accuracy and Safety and Label Clarity The Pharmacy Department of Miracle Hospital has ordered premixed solutions of cyclophosphamide 200 mg per 500 mL of NaCl 0.9%w/v injection from a specialty pharmacy compounding various parenteral products. The commercial 500 mL NS solution PVC bag has an overfill. The specialty pharmacy prepared the cyclophosphamide admixture by adding 10 mL of a reconstituted solution of 20 mg/mL cyclophosphamide to the 500 mL of NaCl 0.9%w/v PVC bag and labelled the IV admixture as 200 mg of cyclophosphamide per 500 mL. What is the concentration per millilitre of the cyclophosphamide admixture? (Napra 3.1) What volume of this admixture would you draw-up in a syringe to deliver a 40 mg dose? (Napra 3.1) What potential error could result if the premixed cytotoxic admixture is used? (Napra 6.1, 6.2, 9.2) Case Study Having Knowledge of the Clinical Use of Specialty Parenteral Solutions Mark…
RNSG 1301 Pharmacology Final Exam Study GuideReview the questions, concepts and medications outlined below 1. Compare and contrast mucolytics, decongestants, expectorants, and antihistamines.
Case Study Avoiding Liability John is a licensed pharmacy technician with compounding expertise for both sterile and nonsterile products. The manager of the hospital pharmacy department, Mr. Brown, who is John’s boss, feels that the commercial metronidazole 500 mg injection they buy is consuming 25% of the drug budget, and he would like this cost to be reduced. Mr. Brown asks John to prepare the injection in the pharmacy, since they have the expertise and the facilities and it would be significantly less costly for the organization. 1, Should John proceed with this request? If yes, why? If not, why not? (Napra 1.1, 3.3) 2, What sources could John consult with to justify his decision one way or another? (Napra 1.1, 3.3) 3, What is the potential risk, if any, to him, his manager, and his organization in making this product? (Napra 1.1, 3.3)
Case study 1. Present a treatment or solution to address such case through the guiding questions after the case.
nursing assessment. Please Give possible explanation why the American Heart Association recommend the use of canola oil or olive oil rather than coconut oil in cooking.
Case Study Identifying Intravenous Delivery Systems, Administration Method, Infusion Rate, Stability/Compatibility, and Labelling of an Intravenous Admixture Mr. Blair, a 75-year-old man weighing 60 kg, was admitted to the Gastroenterology Unit of the Miracle Hospital with severe diarrhea due to food poisoning. After examining Mr. Blair, Dr. Clark ordered IV fluids of D5W 1000 mL q12h, for the next three days with added electrolytes, such as potassium, sodium, calcium, and magnesium, since Mr. Blair was severely dehydrated. In addition, suspecting Salmonella poisoning, Dr. Clark prescribed Septra, 500 mg IV q12h, to be mixed in the D5W electrolytes fluid admixture. What considerations must be taken into account prior to admixing this order? (NAPRA 6.1, 6.2, 8.3, 9.2) 2.If the drug is determined to be incompatible with D5W and electrolytes, what IV delivery system and/or administration method would you use to administer the medication? (NAPRA 2.3, 6.1, 6.2, 8.3, 9.2)…
Analgesia plan for a cat with urinary obstruction: Buprenorphine (for pain) 4.54kgx0.03mg/kg =0.1362mg÷0.3mg/ml=0.45ml Meloxicam (Anti-inflammatory): 4.54 kg x 0.3 mg/kg = 1.3662 mg ÷ 5 mg/ml = 0.27 ml * Please calculate for 4 days, since the cat will remain in the hospital for 4 days.
State and explain the rationale for differences in "Non-invasive monitoring" for adult vs pediatric. [Non-invasive monitoring may include noninvasive BP measurement, pulse oximetry, capnography, and nasopharyngeal and bladder temperature]
RNSG 1301 Pharmacology 8. If a client is unresponsive to first-line treatment for hypertension, combinationtreatment may be indicated. What medications may be used and what labs would youmonitor with each?
Clinical reasoning Scenario: A 36-year-old man who is obese and has a history of diabetes is admitted to the post anaesthesia carer unit (PACU) following a laparoscopic procedure and is scheduled to be discharged home. What are your first three priorities for immediate care of this patient in the PACU?